Evidence map›Paper›PMID 19646905›Full record

ArticleImmunity2009

Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR.

Noelia A-Gonzalez, Steven J Bensinger, Cynthia Hong, Susana Beceiro, Michelle N Bradley, Noam Zelcer, Jose Deniz, Cristina Ramirez, Mercedes Díaz, German Gallardo and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 405 papers.

0numbers the graph read from it
0cells of the map it votes in
405citing papers in PubMed
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

405 citing papers in PubMed, 662 citations in OpenAlex.

  1. Review
  2. Macrophage peroxisomes at the crossroads of inflammation.Immunometabolism (Cobham, Surrey) · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

345 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Noelia A-GonzalezImmune Signaling Laboratory, Department of Biochemistry and Molecular Biology, School of Medicine, University of Las Palmas, ULPGC, 35016 Las Palmas, Spain.
Steven J Bensinger
Cynthia Hong
Susana Beceiro
Michelle N Bradley
Noam Zelcer
Jose Deniz
Cristina Ramirez
Mercedes Díaz
German Gallardo
Carlos Ruiz de Galarreta
Jon Salazar
Felix Lopez
Peter Edwards
John Parks
Miguel Andujar
Peter Tontonoz
Antonio Castrillo
Universidad de Las Palmas de Gran Canaria · ESUniversity of California, Los Angeles · USHoward Hughes Medical Institute · USHospital Materno-Infantil · ESWake Forest University · US

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
ULTRASTRUCTURE OF THE INTIMA IN EARLY LESION FORMATIONP01HL030568 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FOGELMAN, ALAN M · 1985 to 2019
$55.2M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANTON, PETER A · 1991 to 2018
$39.9M
TISSUE CULTURE COREP01HL049373 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI SHELNESS, GREGORY S · 1993 to 2012
$23.8M
NUCLEAR RECEPTOR SIGNALING PATHWAYS IN ATHEROGENESISR01HL066088 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TONTONOZ, PETER J · 2001 to 2018
$5.4M
UCLA Imaging Resource for Mouse Cancer ModelsR24CA092865 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PHELPS, MICHAEL E · 2001 to 2006
$4.3M
Methods for Quantitative Mouse PET StudiesR01EB001943 · NIBIB · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HUANG, SUNG-CHENG · 2004 to 2011
$2.7M
The UCLA Imaging Resource for Mouse Cancer ModelsU24CA092865 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHATZIIOANNOU, ARION XENOFON, PHELPS, MICHAEL E · 2007 to 2011
$2.2M
Howard Hughes Medical InstituteNCI NIH HHS CA16042NCI NIH HHS CA92865NCI NIH HHS P30 CA016042NCI NIH HHS R24 CA092865NCI NIH HHS U24 CA092865NHLBI NIH HHS HL030568NHLBI NIH HHS HL049373NHLBI NIH HHS HL066088NHLBI NIH HHS P01 HL030568NHLBI NIH HHS P01 HL049373NHLBI NIH HHS R01 HL066088NIAID NIH HHS AI28697NIAID NIH HHS P30 AI028697NIBIB NIH HHS EB001943NIBIB NIH HHS R01 EB001943
6 · The paper itself

Abstract

Effective clearance of apoptotic cells by macrophages is essential for immune homeostasis. The transcriptional pathways that allow macrophages to sense and respond to apoptotic cells are poorly defined. We found that liver X receptor (LXR) signaling was important for both apoptotic cell clearance and the maintenance of immune tolerance. Apoptotic cell engulfment activated LXR and thereby induced the expression of Mer, a receptor tyrosine kinase critical for phagocytosis. LXR-deficient macrophages exhibited a selective defect in phagocytosis of apoptotic cells and an aberrant proinflammatory response to them. As a consequence of these defects, mice lacking LXRs manifested a breakdown in self-tolerance and developed autoantibodies and autoimmune glomerulonephritis. Treatment with an LXR agonist ameliorated disease progression in a mouse model of lupus-like autoimmunity. Thus, activation of LXR by apoptotic cells engages a virtuous cycle that promotes their own clearance and couples engulfment to the suppression of inflammatory pathways.

Indexed as

AnimalsApoptosisAutoimmune DiseasesAutoimmunityc-Mer Tyrosine KinaseDNA-Binding ProteinsGene Expression RegulationImmune ToleranceLiver X ReceptorsMacrophagesMiceMice, Inbred C57BLMice, KnockoutOrphan Nuclear ReceptorsPhagocytosisProto-Oncogene Proteinsc-Mer Tyrosine KinaseDNA-Binding ProteinsLiver X ReceptorsMertk protein, mouseOrphan Nuclear ReceptorsProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesReceptors, Cytoplasmic and Nuclear

Identifiers

PMID19646905
PMCPMC2791787
OpenAlexW2095474336

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.